Aziyo Biologics Announces Publication Of A CanGaroo Case Study Demonstrating Bioenvelope Benefits For Reoperative Procedures
Portfolio Pulse from Benzinga Newsdesk
Aziyo Biologics has announced the publication of a CanGaroo case study that demonstrates the benefits of Bioenvelope for reoperative procedures. The case provides the first histologic evidence that CanGaroo can catalyze the development of new healthy tissue layer within an existing cardiac implantable electronic device (CIED) pocket.

August 30, 2023 | 12:37 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The publication of a positive case study about Aziyo Biologics' product CanGaroo could potentially boost the company's reputation and increase demand for its products.
The publication of a positive case study about a company's product often leads to increased visibility and credibility for the company, potentially leading to increased demand for the product. This could have a positive impact on Aziyo Biologics' stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100